Effect of HCV status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication

por McNicholas, Laura F., Holbrook, Amber M., O’Grady, Kevin, Jones, Hendrée E., Coyle, Mara G., Martin, Peter R., Heil, Sarah H., Stine, Susan M., Kaltenbach, Karol
Publicado no Addiction (2012)

Sublingual Buprenorphine/Naloxone for Chronic Pain in At-Risk Patients: Development and Pilot Test of a Clinical Protocol

por Rosenblum, Andrew, Cruciani, Ricardo A., Strain, Eric C, Cleland, Charles M., Joseph, Herman, Magura, Stephen, Marsch, Lisa A, McNicholas, Laura F, Savage, Seddon R, Sundaram, Arun, Portenoy, Russell K.
Publicado em 2012

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder

por Crist*, Richard. C., Phillips, Karran. A., Furnari, Melody. A., Moran, Landhing. M., Doyle, Glenn. A., McNicholas, Laura. F., Cornish, James. W., Kampman, Kyle. M., Preston, Kenzie. L., Berrettini, Wade. H.
Publicado no Pharmacogenomics J (2018)